Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2009
12/29/2009US7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists
12/29/2009US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/29/2009US7638530 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents
12/29/2009US7638509 Diene compounds and formulations
12/29/2009US7638484 Methods for accelerating wound healing by administration of adipokines
12/29/2009US7638481 With vaccinia virus complement control protein, poxvirus encoded
12/29/2009US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/29/2009US7638272 administering a polypeptide to the cancer cells of the mammal in vivo for sensitizing the cancer cells to the therapeutic chemotherapy, radiation treatment; gene expressed polypeptide; secreted protein acidic and rich in cystein
12/29/2009US7638134 Insertion sites in fowlpox vectors
12/29/2009CA2418829C Process for the preparation of baccatin iii derivatives
12/24/2009US20090318472 Aminopyrazine derivatives and compositions
12/24/2009US20090318438 Heterocyclic compounds and their use as anticancer agents
12/24/2009US20090318357 Molecules Preferentially Associated with Effector T Cells or Regulatory T Cells and Methods of Their Use
12/24/2009US20090318334 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
12/24/2009US20090317907 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
12/24/2009US20090317816 Methods for identifying risk of breast cancer and treatments thereof
12/24/2009US20090317357 Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents
12/23/2009EP1608654B1 8-SUBSTITUTED-6, 7, 8,9-TETRAHY9DROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/23/2009CN100572390C Inhibitor of stem cell proliferation and uses thereof
12/23/2009CN100572379C Cgrp receptor antagonists
12/23/2009CN100572364C HIV replication inhibiting pyrimidines and triazines
12/23/2009CN100571787C Para-hydrogen labelled agents and their use in magnetic resonance imaging
12/23/2009CN100571772C Use of integrin receptor alpha v beta 3 and /or alpha v beta 5 antagonist in preparing medicine for treating eye disease
12/23/2009CN100571676C Cosmetic method and composition for enhancing attraction
12/22/2009US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/22/2009CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009CA2486859C Combination immediate release controlled release levodopa/carbidopa dosage forms
12/22/2009CA2387973C Pharmaceutical formulation containing tolterodine and its use
12/22/2009CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
12/22/2009CA2322327C Treatment of viral disease in swine
12/22/2009CA2296141C Association of two cationic dyes for use in direct dyeing of keratinic fibres
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009US20090312524 Compositions and methods comprising collagen
12/17/2009US20090312424 Aromatic prodrugs of propofol, compositions and uses thereof
12/17/2009US20090312403 Compositions and methods for wt1 specific immunotherapy
12/17/2009US20090312276 Compositions and Methods for Treating Cancer
12/17/2009US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
12/17/2009US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
12/16/2009EP2133348A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
12/16/2009EP1434603B1 Method of treatment using ligand-immunogen conjugates
12/16/2009CN101602807A Mammalian cytokines, reagent and method thereof
12/16/2009CN100569798C GLP-1 derivative
12/16/2009CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability
12/16/2009CN100569255C Nitric oxide and its biomedical significance
12/16/2009CN100569228C Fatty acid analogues for treatment of cancer
12/15/2009US7632972 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
12/15/2009US7632822 For prophylaxis and therapy of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, asthma or a disease caused by a pathogen
12/15/2009CA2481078C Method and compositions for the synthesis of bch-189 and related compounds
12/10/2009US20090305985 Immunomodulatory Agents For Treatment of Inflammatory Diseases
12/10/2009US20090304741 Yeast-Dendritic Cell Vaccines and Uses Thereof
12/09/2009EP1722802B1 A medical solution, a method for producing said medical solution and use thereof
12/09/2009CN101596151A Antimicrobial breath-refreshing mouthwash
12/08/2009US7629355 Use of e.g. N-[(1R,S)-1-Cyclopropylethyl]-Normorphine for treating opiate, cocaine, or alcohol addiction
12/08/2009US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
12/08/2009US7629320 Oxyamino-pyrazolo[3,4-d]pyrimidinylribofuranose derivatives, e.g., 1-(2'-C-methyl- beta -D-ribofuranosyl)-4-methoxylamino-pyrazolo[3,4-d]pyrimidine and 1-(2'-C-methyl- beta -D-ribofuranosyl)-3-cyano-4-methoxylamino-pyrazolo[3,4-d]pyrimidine
12/08/2009CA2540858C Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
12/03/2009US20090298939 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals
12/03/2009US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents
12/03/2009US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators
12/03/2009US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis
12/03/2009US20090298743 Hydrophobic compositions containing reconstitution enhancer
12/03/2009US20090298174 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
12/03/2009US20090297641 Herbal compositions for the treatment of mucosal lesions
12/03/2009US20090297509 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
12/03/2009US20090297505 Abeta binding molecules
12/03/2009US20090297478 Methods and Compositions for the Treatment of Lupus Using Clofarabine
12/02/2009EP1618086B1 Compounds for the treatment of metabolic disorders
12/02/2009EP1551802B1 Indole-3-sulphur derivatives
12/02/2009CN100564426C Water-soluble polyamioamides as sunscreen agents
12/02/2009CN100564358C Method for making 4-(3,4-dichlorophenoxy)piperidine
12/01/2009US7625995 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
12/01/2009US7625928 Prevent, therapy of side effect of radiotherapy; applying to skins, mucous membranes
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625872 a branch-point nucleoside to which three core nucleic acid moieties are covalently coupled; therapy for cancer and Th2-type immune response (e.g., an allergy or allergy-induced asthma) by increasing the secretion of interferon-gamma
12/01/2009US7625861 Copolymer-1 improvements in compositions of copolymers
11/2009
11/26/2009US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/26/2009US20090292004 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
11/26/2009US20090291939 Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking
11/26/2009US20090291909 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
11/26/2009US20090291907 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
11/26/2009US20090291906 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
11/26/2009US20090291886 Transmucosal delivery of peptides and proteins
11/26/2009US20090291090 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
11/25/2009EP2123675A2 Human EPO mimentic hinge core mimetibodies, compositions, methods and uses
11/25/2009EP1618106B1 Carbacephem beta-lactam antibiotics
11/25/2009EP1268509B1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
11/25/2009CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/24/2009US7622571 Methods and compositions for Mycoplasma pneumoniae exotoxins
11/24/2009US7622468 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl)-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-diphdro-1N-pyrrol-1-carboxamide
11/24/2009US7622124 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant
11/24/2009US7622107 Recombinant intracellular pathogen immunogenic compositions and methods for use
11/24/2009CA2480668C Compositions comprising dietary fat complexer and methods for their use
11/19/2009US20090286969 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
11/19/2009US20090285858 Prevention of allergy in children
11/19/2009US20090285853 Nucleic Acids Encoding Respiratory Syncytial Virus Subgroup B strain 9320
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090285828 Anti-PECAM Therapy for Metastasis Suppression
11/19/2009US20090285783 Methods and compositions for cancer therapy using a novel adenovirus
11/19/2009US20090285777 Uses of Mammalian Cytokine; Related Reagents
11/18/2009EP1587474B1 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 295